OneMedNet Swings to Profitability, Rides Palantir Partnership
Event summary
- OneMedNet revenue surged 329% year-over-year to $1.254 million in 2025, from $292,000 in 2024.
- The company significantly reduced total liabilities by 74%, decreasing from $19.7 million to $5.1 million, through settlements and debt-to-equity conversions.
- Shareholder deficit was substantially reduced from $(16.0) million to $(3.0) million.
- OneMedNet is piloting its AI-driven iRWD™ platform with two customers, anticipating four more in 2026, each with a seven-figure subscription potential.
- The company sunset its BEAM solution, eliminating associated expenses and focusing on its Real-World Data business.
The big picture
OneMedNet's turnaround, marked by substantial revenue growth and a dramatically improved balance sheet, signals a potential shift in the Real-World Data landscape. The partnership with Palantir Foundry positions the company to capitalize on the increasing demand for AI-powered data analytics in healthcare, but also introduces a key dependency. The company's transition to a subscription-based model is a positive sign, but hinges on consistent customer acquisition and retention.
What we're watching
- Execution Risk
- The ability to onboard the anticipated four additional customers in 2026, each representing a seven-figure subscription, will be critical to sustaining the current growth trajectory and validating the platform's commercial appeal.
- Palantir Dependency
- OneMedNet’s reliance on Palantir Foundry introduces a dependency risk; changes in Palantir’s pricing, technology, or strategic direction could materially impact OneMedNet’s platform and competitive advantage.
- Scalability
- The projected 4x platform growth by the end of 2026 requires significant operational scaling, and whether OneMedNet can manage this expansion without compromising data quality or customer service remains to be seen.
Related topics